BIO-TECHNE Corp vs Veritone Inc — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while Veritone Inc trades at $1.13 (market cap $97.60M). The key difference: BIO-TECHNE Corp is far larger — about 114.3× Veritone Inc's market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Veritone Inc pays none. Which is the better fit depends on your goals.
| TECH | VERI | |
|---|---|---|
Market Cap | $11.16B | $97.60M |
Sector | Health | Technology |
52-Week High | $72.12 | $8.39 |
52-Week Low | $43.31 | $1.02 |
Enterprise Value | $11.24B | $129.63M |
Dividend Yield | 0.45% | — |
Trailing returns across standard periods
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →